These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10357475)

  • 21. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
    Baba TW; Liska V; Khimani AH; Ray NB; Dailey PJ; Penninck D; Bronson R; Greene MF; McClure HM; Martin LN; Ruprecht RM
    Nat Med; 1999 Feb; 5(2):194-203. PubMed ID: 9930868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.
    Cranage MP; Sharpe SA; Whatmore AM; Polyanskaya N; Norley S; Cook N; Leech S; Dennis MJ; Hall GA
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1935-44. PubMed ID: 9714241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative approach to retroviral vaccines.
    Burny A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
    [No Abstract]   [Full Text] [Related]  

  • 25. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summary of the SIV Working Group.
    Schultz AM
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977
    [No Abstract]   [Full Text] [Related]  

  • 27. Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus.
    Gardner MB; Luciw PA; Sawai ET; Marthas ML; Miller CJ; McChesney MB; Lerche NW; Pedersen NC
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):399-401. PubMed ID: 8882318
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 29. AIDS vaccine developments.
    Le Grand R; Vaslin B; Vogt G; Roques P; Humbert M; Dormont D
    Nature; 1992 Feb; 355(6362):684. PubMed ID: 1741053
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV vaccines--where are we going?
    Heilman CA; Baltimore D
    Nat Med; 1998 May; 4(5 Suppl):532-4. PubMed ID: 9585205
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections.
    Dittmer U; Hasenkrug KJ
    Curr Mol Med; 2001 Sep; 1(4):431-6. PubMed ID: 11899087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated vaccines for AIDS?
    Ruprecht RM; Baba TW; Greene MF
    Lancet; 1995 Jul; 346(8968):177-8. PubMed ID: 7603239
    [No Abstract]   [Full Text] [Related]  

  • 33. Attenuated vaccines for AIDS.
    Victorino RM; Sousa AE
    Lancet; 1995 Jul; 346(8968):179. PubMed ID: 7603240
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against establishment of retroviral persistence by vaccination with a live attenuated virus.
    Dittmer U; Brooks DM; Hasenkrug KJ
    J Virol; 1999 May; 73(5):3753-7. PubMed ID: 10196269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choosing the right memory T cell for HIV.
    Franchini G
    Nat Med; 2009 Mar; 15(3):244-6. PubMed ID: 19265821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS research. New findings cast doubt on UK vaccine trials.
    Anderson C
    Nature; 1991 Sep; 353(6342):287. PubMed ID: 1822967
    [No Abstract]   [Full Text] [Related]  

  • 37. CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.
    Stebbings R; Berry N; Waldmann H; Bird P; Hale G; Stott J; North D; Hull R; Hall J; Lines J; Brown S; D'Arcy N; Davis L; Elsley W; Edwards C; Ferguson D; Allen J; Almond N
    J Virol; 2005 Oct; 79(19):12264-72. PubMed ID: 16160152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.
    Dittmer U; Race B; Hasenkrug KJ
    J Virol; 1999 Oct; 73(10):8435-40. PubMed ID: 10482595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines.
    Dittmer U; Hasenkrug KJ
    AIDS Res Hum Retroviruses; 1999 May; 15(8):785. PubMed ID: 10357475
    [No Abstract]   [Full Text] [Related]  

  • 40. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.